Expert-Led Assessment Services for Strategic Acquisitions and Partnerships
To know more about the rules,
Please Fill the Form
To learn more, connect with us
As Indian medical device manufacturers expand into international markets, complying with the regulatory requirements of highly regulated countries such as the US presents a significant challenge. Choosing the appropriate registration pathway with the U.S. FDA whether it be the 510(k), De Novo, or PMA route, is the major challenge. This step is key to regulatory due diligence for Indian manufacturers.
At CliniExperts, we specialize in conducting in-depth US regulatory due diligence tailored specifically for Indian manufacturers. Our services are built to provide a full-spectrum compliance risk assessment—covering route selection, technical documentation, QMS, post-market surveillance, and facility readiness.
Verification of the appropriate FDA regulatory pathway, based on factors, to facilitate a smoother registration process.
Identifying potential non-conformities of clinical data or outdated studies.
Verifying QMS compliance with ISO 13485:2016 and 21 CFR Part 820 (FDA QSR).
Exposing gaps in PMS/PSUR, CAPA handling, and vigilance systems that may impact valuation.
Entering the US market or acquiring a American manufacturer demands far more than financial feasibility and product portfolio alignment. Regulatory Due Diligence is the gatekeeper to assessing the true operational and commercial value of the target.
Comprehensive evaluation of certificates, scope, and conformity routes
Assessment of technical files, clinical evaluations, and risk management
Analysis of labeling, IFUs, and claims substantiation
Verification of ISO 13485:2016 compliance and QMSR readiness
Review of vigilance systems and field safety procedures
Assessment of regulatory correspondence and certification status
Evaluate certificates, scope, expiration, and conformity routes based on multiple factors.
Assess alignment of the product classification and GMDN coding.
Review any conditions imposed by the Regulatory Body.
Evaluate documentation FD&C Act + 21 CFR of USFDA.
Assess clinical evaluation data and risk management files.
Post market Surveillance documentation.
Assess language requirements, UDI implementation, and claims substantiation.
Check traceability elements and alignment with UDI-DI (if applicable).
Analyze labeling and IFUs for compliance with 21 CFR Part 801 of USFDA.
Audit facility compliance with international standards.
Assess internal practices and management review efficacy.
Evaluate readiness for unannounced audits.
Audit facility compliance with ISO 13485:2016 and QSMR. Assess internal audit practices, management review efficacy, and document controls. Evaluate readiness for unannounced audits and Notified Body inspections.
Review PSURs, PMS reports, vigilance history, and trend analysis records.
Evaluate Field Safety Corrective Actions (FSCA) and incident investigation quality.
Assess integration with MAUDE vigilance modules.
CliniExperts is your strategic partner for technical and regulatory due diligence in EU device transactions. We empower Indian manufacturers with precision insight to navigate the European regulatory landscape confidently.